Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

RTTNews | 1034 일 전
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.

EGFR inhibitors are critical therapeutic agents for the treatment of non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer, squamous-cell carcinoma of the head and neck, and breast cancer.

The company said this trial brings us one step closer to a new treatment option for underserved cancer patients as there is no specific treatment currently approved for the treatment of skin toxicities associated with EGFRi therapies.

The company added it will advance HT-001 into the clinical phase as it is a key treatment in the onco-dermatology space and anticipates beginning the Phase 2a trial in the first quarter of 2023.

read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | 778 일 전
Australian Market Sharply Extends Early Losses In Mid-market

Australian Market Sharply Extends Early Losses In Mid-market

The Australian stock market is sharply expending its early losses in mid-market moves on Wednesday, reversing the losses in the previous session, with the benchmark S&P/ASX 200 falling below the 8,950 level, despite the broadly positive cues from Wall Street overnight, as domestic inflation jumped higher-than-expected, with weakness in financial and technology stocks.>
RTTNews | 1 시간 33 분 전
Asian Markets Trade Mixed

Asian Markets Trade Mixed

Asian stock markets are trading mixed on Wednesday, following the broadly positive cues from Wall Street overnight, as traders remain cautious and are reluctant to make more significant moves ahead of the U.S. Fed's interest rate decision later in the day and are optimistic about a potential trade deal between the U.S. and China. Asian markets closed mostly lower on Tuesday.
RTTNews | 1 시간 57 분 전
Thai Shares May See Renewed Support On Wednesday

Thai Shares May See Renewed Support On Wednesday

The Thai stock market on Tuesday ended the five-day winning streak in which it had picked up more than 50 points or 3.9 percent. The Stock Exchange of Thailand now rests just shy of the 1,315-point plateau although it may tick higher again on Wednesday.
RTTNews | 3 시간 2 분 전